Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biontech Se ADR
(NQ:
BNTX
)
108.97
-2.51 (-2.25%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biontech Se ADR
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
64
65
Next >
US Government Offers $75M Support For Lipid Systems Expansion Used In mRNA COVID-19 Vaccines
June 28, 2022
Via
Benzinga
Why Pfizer Partner BioNTech Shares Are Rising Today
June 27, 2022
BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by 6.31% at $142.50 after the company announced its Omicron-adapted COVID-19 vaccine candidates demonstrated high immune response against the...
Via
Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
June 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Pfizer/BioNTech's Updated Omicron-Based COVID-19 Shots Show Improved Response Against Variant
June 27, 2022
Via
Benzinga
BioNTech Whale Trades Spotted
June 17, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on BioNTech. Looking at options history for BioNTech (NASDAQ:BNTX) we detected 14 strange trades.
Via
Benzinga
7 Biotech Stocks With Key Catalysts Coming in July
June 27, 2022
Biotech stocks have had a rocky few months, but many are on the mend. These picks should provide investors both flexibility and growth.
Via
InvestorPlace
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
June 25, 2022
From
Pfizer Inc.
Via
Business Wire
The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial
June 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
BioNTech Gets EMA's Priority Medicines Status For Testicular Cancer Drug
June 23, 2022
BioNTech (NASDAQ: BNTX) received Priority Medicines (PRIME) designation from the European Medicines Agency (EMA) for its product candidate BNT211 in the third- or later-line treatment of testicular...
Via
Benzinga
7 Long-Term Stocks to Buy in a Bear Market
June 20, 2022
These long-term stocks to buy are from defensive sectors, because now is the time to play defense in your stock investing.
Via
InvestorPlace
Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Nod For Kids As Young As Six Months
June 17, 2022
Via
Benzinga
Pfizer, Moderna Snag FDA OK For Covid Shots In Children At 6 Months Old
June 17, 2022
The decision expands Covid shots out to the last group to become eligible.
Via
Investor's Business Daily
Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age
June 17, 2022
From
Pfizer Inc.
Via
Business Wire
Bavarian Nordic Launches COVID-19 Booster Study To Compare Against Pfizer/BioNTech Shot
June 16, 2022
Via
Benzinga
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
June 16, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
FDA Committee Backs Pfizer, Moderna COVID-19 Vaccines For Toddlers, Youngest Children
June 16, 2022
The FDA's Vaccines and Related Biological Products Advisory Committee voted i
Via
Benzinga
As Omicron Surges, FDA Mulls Pfizer, Moderna Covid Shots For Babies
June 15, 2022
Pfizer studied a three-dose regimen. Moderna looked at two doses.
Via
Investor's Business Daily
The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data
June 15, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Wednesday, June 15
June 15, 2022
Reuters Warner Bros Discovery To Undergo Major Global Ad Sales Team Restructuring
Via
Benzinga
FDA Committee Backs Moderna's COVID-19 Shot For Kids, Adolescents: Report
June 15, 2022
Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccine received unanimous backing from the FDA's committee of independent immunization experts for children ages 6 through 17.
Via
Benzinga
EU Urges Pfizer To Further Delay COVID-19 Vaccine Deliveries: Reuters
June 14, 2022
Via
Benzinga
Moderna's COVID-19 Shot Likely Related To Higher Heart Inflammation Risk Than Pfizer's: Reuters
June 14, 2022
Via
Benzinga
IBD/TIPP Poll: There's Bad News For Novavax's Covid Vaccine
June 14, 2022
Here's why its protein-based shot could struggle in the U.S.
Via
Investor's Business Daily
Moderna's Pediatric Covid Shot Is On Deck At The FDA: Here's What To Know
June 14, 2022
The FDA's vaccine experts will later vote on whether to recommend the shot.
Via
Investor's Business Daily
FDA Backs Pediatric Covid Shots; Here's Why Pfizer, Moderna Shares Crumbled
June 13, 2022
The FDA says Covid shots for children under the age of 5 are safe and effective.
Via
Investor's Business Daily
5 Biotech Stocks To Watch During The Week Of June 13
June 13, 2022
Biotech stocks continued to be under pressure in the past week amid broader market weakness, precipitated by economic worries. Company-specific developments also triggered downward moves. Here's a...
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Monday, June 13
June 13, 2022
CNBC JPMorgan Remains Bullish On Alibaba And Other Chinese Stocks - Here’s Why
Via
Benzinga
Moderna's COVID-19 Vaccine Shows Safety, Effectiveness For Children Under 17 Years
June 13, 2022
Via
Benzinga
Pfizer/BioNTech's Three-Dose COVID-19 Vaccine Safe, Effective In Younger Kids
June 13, 2022
According to the FDA briefing document, Pfizer Inc (NYSE: PFE) -BioNTech's SE (NASDAQ:
Via
Benzinga
Sanofi-GSK's Next-Gen COVID-19 Booster Shows Potential Against Variants Of Concern
June 13, 2022
Via
Benzinga
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
64
65
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.